caprelsarems.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | CAPRELSA® (vandetanib) REMS Program | Advanced Medullary Thyroid Carcinoma |
| Description | Welcome to the CAPRELSA REMS Information for the CAPRELSA REMS Program. CAPRELSA<sup>®</sup> (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid cancer treatment in patients with unresectable locally advanced or |
| Keywords | medullary thyroid cancer treatment, CAPRELSA, vandetanib, medullary thyroid cancer, unresectable locally advanced medullary thyroid cancer, metastatic medullary thyroid cancer |
Server Information
| WebSite | |
| Host IP | 54.247.151.159 |
| Location | Ireland |
Related Websites
| Site | Rank |
More to Explore
caprelsarems.com Valuation
|
US$1,223,232
Last updated: 2023-05-14 13:52:59
caprelsarems.com has Semrush global rank of 8,652,736. caprelsarems.com has an estimated worth of US$ 1,223,232, based on its estimated Ads revenue. caprelsarems.com receives approximately 141,143 unique visitors each day. Its web server is located in Ireland, with IP address 54.247.151.159. According to SiteAdvisor, caprelsarems.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,223,232 |
| Daily Ads Revenue | US$1,130 |
| Monthly Ads Revenue | US$33,875 |
| Yearly Ads Revenue | US$406,490 |
| Daily Unique Visitors | 9,410 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| caprelsarems.com. | A | 900 | IP: 54.247.151.159 |
| caprelsarems.com. | NS | 900 | NS Record: ns3.sanofi-synthelabo.com. |
| caprelsarems.com. | NS | 900 | NS Record: ns4.sanofi-synthelabo.com. |
| caprelsarems.com. | NS | 900 | NS Record: ns1.sanofi-synthelabo.com. |
| caprelsarems.com. | NS | 900 | NS Record: ns2.sanofi-synthelabo.com. |
| caprelsarems.com. | MX | 900 | MX Record: 10 mailerb.sanofi.com. |
| caprelsarems.com. | MX | 900 | MX Record: 10 mailera.sanofi.com. |
| caprelsarems.com. | TXT | 900 | TXT Record: 75z09hw7yc41fr55cj6hwbt8yf18rjjj |
HtmlToTextCheckTime:2023-05-14 13:52:59
| Prescribing CAPRELSA Prescribing Information for CAPRELSA CAPRELSA Prescription Form CAPRELSA Patient Brochure REMS Home Educational Materials Learn About the CAPRELSA REMS Program Enroll In the CAPRELSA REMS Program Contact Us --> This site is intended for US Healthcare Professionals Print Page Welcome to the CAPRELSA REMS Program CAPRELSA ® (vandetanib) Tablets, a kinase inhibitor, is approved by the Food and Drug Administration (FDA) for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. Use CAPRELSA in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA. CAPRELSA can prolong the QT interval and cases of Torsades de pointes and sudden death have occurred in patients receiving CAPRELSA. Because of this risk, CAPRELSA is only available through the CAPRELSA Risk Evaluation and Mitigation Strategy (REMS) |
HTTP Headers
HTTP/1.1 302 Found Date: Thu, 23 Dec 2021 12:44:27 GMT Server: Apache/2.4.48 () Location: https://www.caprelsarems.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 302 content-type: text/html content-length: 131 date: Thu, 23 Dec 2021 12:44:27 GMT set-cookie: AWSALB=BuKMaYbsEAuduIsWDvtzHFPBbl5bQb0freTgc6CoViAiNY70Um/V33Bml6E4PDgmi0lipjZGmGyab1m5/4ZIB+YghLwdufBXYiWHYdsii5xdrfF1SOsyrBoTvPmu; Expires=Thu, 30 Dec 2021 12:44:27 GMT; Path=/ set-cookie: AWSALBCORS=BuKMaYbsEAuduIsWDvtzHFPBbl5bQb0freTgc6CoViAiNY70Um/V33Bml6E4PDgmi0lipjZGmGyab1m5/4ZIB+YghLwdufBXYiWHYdsii5xdrfF1SOsyrBoTvPmu; Expires=Thu, 30 Dec 2021 12:44:27 GMT; Path=/; SameSite=None; Secure cache-control: private location: /index.asp server: Microsoft-IIS/10.0 set-cookie: ASPSESSIONIDAASQBBBB=HGKJIPACBFFNONIHLGBCIPAN; path=/ x-powered-by: ASP.NET x-cache: Miss from cloudfront via: 1.1 74636a0d3b110dc164c7801b27cac3b3.cloudfront.net (CloudFront) x-amz-cf-pop: JFK51-C1 x-amz-cf-id: 0Gsx7da-pEyDJwxDJg6w3ygX6qKEyqRL2oC3OSn4tFXt4H2wG9Yfqg== HTTP/2 200 content-type: text/html content-length: 16463 date: Thu, 23 Dec 2021 12:44:27 GMT set-cookie: AWSALB=mB8VZgcl/lP7MSBQyQQ+9YsqCDdI1nptreoRkiTGLi2fb2oHqH/5u+CNxBsQRFYi3Wudyk6chVuJILXpRgNmtopZfTvKtKfShP4LWpCDKW5vpGj5Ag+yduWzZHCm; Expires=Thu, 30 Dec 2021 12:44:27 GMT; Path=/ set-cookie: AWSALBCORS=mB8VZgcl/lP7MSBQyQQ+9YsqCDdI1nptreoRkiTGLi2fb2oHqH/5u+CNxBsQRFYi3Wudyk6chVuJILXpRgNmtopZfTvKtKfShP4LWpCDKW5vpGj5Ag+yduWzZHCm; Expires=Thu, 30 Dec 2021 12:44:27 GMT; Path=/; SameSite=None; Secure cache-control: private server: Microsoft-IIS/10.0 set-cookie: ASPSESSIONIDAASQBBBB=IGKJIPACGJKAGAJPEDLEHFGA; path=/ x-powered-by: ASP.NET x-cache: Miss from cloudfront via: 1.1 74636a0d3b110dc164c7801b27cac3b3.cloudfront.net (CloudFront) x-amz-cf-pop: JFK51-C1 x-amz-cf-id: SoIoJPQ6DmZLnTV4cYAQetWGTtorJjnZjPl9oP1-SY2J5ZHSucj4Bg== |
caprelsarems.com Whois Information
Domain Name: CAPRELSAREMS.COM Registry Domain ID: 1640519040_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-02-12T06:30:00Z Creation Date: 2011-02-16T16:09:21Z Registry Expiry Date: 2022-02-16T16:09:21Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.SANOFI-SYNTHELABO.COM Name Server: NS2.SANOFI-SYNTHELABO.COM Name Server: NS3.SANOFI-SYNTHELABO.COM Name Server: NS4.SANOFI-SYNTHELABO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T07:25:12Z <<< |